Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Can Bristol-Myers Squibb Heal Your Portfolio?
Seeking Alpha
Thursday, May 20, 2010 - 11:18am
tags:
Bristol-Myers Squibb, investors
Encouraging Data Presented on Oncophage® Vaccine at International Conference on Brain Tumor Research and Therapy
Yahoo/BusinessWire
Thursday, May 20, 2010 - 11:16am
tags:
Oncophage, brain cancer, Antigenics, cancer vaccines
Enzon Pharmaceuticals: Value Investment or Simply Speculation
Seeking Alpha
Thursday, May 20, 2010 - 11:15am
tags:
Enzon, PEG-SN38, PEGylation, investors
What Investors Think About XenoPort
Motley Fool
Thursday, May 20, 2010 - 11:13am
tags:
XenoPort
Forest Labs Draws Bullish Call Position
TheStreet.com
Thursday, May 20, 2010 - 6:22am
tags:
Forest Labs
Is SIGA Still Worth the Wait?
Seeking Alpha
Thursday, May 20, 2010 - 6:22am
tags:
SIGA technologies
FDA plan would share drug rejections
Boston Globe, MA
Thursday, May 20, 2010 - 6:19am
tags:
FDA, rejections
NovaBay Pharmaceuticals: CEO Interview
TheStreet.com
Thursday, May 20, 2010 - 6:18am
tags:
Pharma CEOs, NovaBay Pharmaceuticals, Alcon, Galderma
More on the ‘Game Changing’ Novartis Verdict
WSJ Online
Thursday, May 20, 2010 - 6:14am
tags:
Novartis, discrimination, lawsuits
ASCO's Abstract Release Day: Preview
TheStreet.com
Wednesday, May 19, 2010 - 7:07pm
tags:
oncology, cancer, ASCO, Celldex, Keryx, Delcath, Sunesis, Ziopharm, Pharmacyclics, OncoGenex
Getting Beyond The Corporate Culture At Pfizer
Forbes
Wednesday, May 19, 2010 - 7:06pm
tags:
Pfizer, generics, corporate culture
J&J Scandal Hearing May Be Postponed
Pharmalot
Wednesday, May 19, 2010 - 6:17pm
tags:
JNJ, recalls
Who's Going to Get What in the $250M Novartis Sex Discrimination Verdict
BNET Pharma
Wednesday, May 19, 2010 - 6:12pm
tags:
Novartis, lawsuits, discrimination
Orphan Status for Allos Drug
Yahoo/Zacks.com
Wednesday, May 19, 2010 - 6:10pm
tags:
Allos, orphan drugs, Pralatrexate, bladder cancer
Teva gets OK to market generic Lipitor in Canada
Yahoo/AP
Wednesday, May 19, 2010 - 6:09pm
tags:
Teva Pharmaceuticals, generics, Lipitor, Canada, Pfizer
A Potential Blockbuster Bites the Dust. Should You Worry?
Motley Fool
Wednesday, May 19, 2010 - 6:08pm
tags:
Biogen Idec, ocrelizumab, Roche, rheumatoid arthritis
Pharma execs expect fines, M&A and easier credit
Fierce Pharma
Wednesday, May 19, 2010 - 5:02pm
tags:
M&A, fines, credit rating
St. Jude's and Glaxo Find Early Clues to Potential Malaria Drugs
WSJ Online
Wednesday, May 19, 2010 - 4:56pm
tags:
St. Jude Medical, GSK
GlaxoSmithKline Cutting Prices to Gain Market Share in China
Seeking Alpha
Wednesday, May 19, 2010 - 4:46pm
tags:
GSK, China, India
Novartis disputes sex discrimination claims
Marketwatch
Wednesday, May 19, 2010 - 4:42pm
tags:
Novartis, lawsuits, discrimination

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.